LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 36.73 | 84.90 | 3018 | 3254 | 0.9274 | 0.9715 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 36.73 | 84.90 | 3079 | 3254 | 0.9461 | 0.9791 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 36.73 | 84.90 | 3153 | 3254 | 0.9689 | 0.9880 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 36.73 | 84.90 | 3227 | 3254 | 0.9916 | 0.9968 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 38.43 | 84.90 | 3236 | 3459 | 0.9354 | 0.9752 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 38.43 | 84.90 | 3303 | 3459 | 0.9547 | 0.9828 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 38.43 | 84.90 | 3400 | 3459 | 0.9828 | 0.9935 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 38.43 | 84.90 | 3454 | 3459 | 0.9984 | 0.9994 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 40.14 | 84.90 | 3506 | 3682 | 0.9522 | 0.9821 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 40.14 | 84.90 | 3567 | 3682 | 0.9688 | 0.9884 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 40.14 | 84.90 | 3591 | 3682 | 0.9753 | 0.9908 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 40.14 | 84.90 | 3643 | 3682 | 0.9894 | 0.9961 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 41.84 | 84.90 | 3709 | 4003 | 0.9265 | 0.9727 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 41.84 | 84.90 | 3784 | 4003 | 0.9453 | 0.9799 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 41.84 | 84.90 | 3831 | 4003 | 0.9570 | 0.9843 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 41.84 | 84.90 | 3923 | 4003 | 0.9800 | 0.9927 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 43.55 | 84.90 | 4011 | 4287 | 0.9354 | 0.9765 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 43.55 | 84.90 | 4075 | 4287 | 0.9503 | 0.9821 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 43.55 | 84.90 | 4100 | 4287 | 0.9562 | 0.9842 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 43.55 | 84.90 | 4177 | 4287 | 0.9741 | 0.9908 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 45.25 | 84.90 | 4245 | 4539 | 0.9351 | 0.9767 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 45.25 | 84.90 | 4333 | 4539 | 0.9544 | 0.9838 | MN20160318_Q02 | E03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 45.25 | 84.90 | 4301 | 4539 | 0.9474 | 0.9813 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 45.25 | 84.90 | 4475 | 4539 | 0.9857 | 0.9950 | MN20160318_Q02 | F06 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0013333 | 46.95 | 84.90 | 4609 | 4952 | 0.9306 | 0.9756 | MN20160318_Q02 | E03 |